ATRICURE CRYO MODULE

K111042 · AtriCure, Inc. · GEH · May 26, 2011 · General, Plastic Surgery

Device Facts

Record IDK111042
Device NameATRICURE CRYO MODULE
ApplicantAtriCure, Inc.
Product CodeGEH · General, Plastic Surgery
Decision DateMay 26, 2011
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4350
Device ClassClass 2
AttributesTherapeutic, 3rd-Party Reviewed

Intended Use

The AtriCure Cryo Module System is intended for use in the cryosurgical treatment of cardiac arrhythmias. The System consists of the AtriCure Cryo Module (ACM)-a non-sterile, reusable device-used with the Cryo1 cryo-ablation probe-a sterile, single use device-and/or the cryolCE cryo-ablation probe-a sterile, single use device.

Device Story

AtriCure Cryo Module (ACM) is an electro-mechanical and pneumatic system for cardiac cryo-ablation; delivers Nitrous Oxide to sterile, single-use cryo-ablation probes (Cryo1 or cryoICE). System creates lines of ablation through cardiac tissue to treat arrhythmias. Used by clinicians in surgical settings. Device is non-sterile and reusable; probes are sterile and single-use. Operation involves pneumatic delivery of cryogenic energy to handpiece; enables targeted tissue destruction. Clinical benefit includes effective treatment of cardiac arrhythmias via controlled cryo-ablation.

Clinical Evidence

Bench testing only. No clinical data provided. Testing included product specification conformance, transit testing, electromagnetic compatibility, and reliability testing to demonstrate substantial equivalence.

Technological Characteristics

Electro-mechanical and pneumatic cryogenic surgical system. Delivers Nitrous Oxide. Non-sterile, reusable module; sterile, single-use probes. Materials are suitable for pressurized nitrous oxide. No patient contact for the module itself.

Indications for Use

Indicated for the cryosurgical treatment of cardiac arrhythmias in patients requiring cardiac ablation.

Regulatory Classification

Identification

(1) Cryosurgical unit with a liquid nitrogen cooled cryoprobe and accessories. A cryosurgical unit with a liquid nitrogen cooled cryoprobe and accessories is a device intended to destroy tissue during surgical procedures by applying extreme cold. (2) Cryosurgical unit with a nitrous oxide cooled cryoprobe and accessories. A cryosurgical unit with a nitrous oxide cooled cryoprobe and accessories is a device intended to destroy tissue during surgical procedures, including urological applications, by applying extreme cold. (3) Cryosurgical unit with a carbon dioxide cooled cryoprobe or a carbon dioxide dry ice applicator and accessories. A cryosurgical unit with a carbon dioxide cooled cryoprobe or a carbon dioxide dry ice applicator and accessories is a device intended to destroy tissue during surgical procedures by applying extreme cold. The device is intended to treat disease conditions such as tumors, skin cancers, acne scars, or hemangiomas (benign tumors consisting of newly formed blood vessels) and various benign or malignant gynecological conditions affecting vulvar, vaginal, or cervical tissue. The device is not intended for urological applications.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # ATRICURE CRYO MODULE 510(k) SUMMARY MAY 2 6 2011 ## General Information | Date Compiled | January 31, 2011 | |----------------|----------------------------------------------------------------------| | Classification | Class II | | Product Code | GEH | | Trade Name | AtriCure Cryo Module | | Manufacturer | AtriCure, Inc<br>6217 Centre Park Drive<br>West Chester, OH 45069 | | Contact | Rebecca Walters, RAC<br>Regulatory Affairs Manager<br>(513) 755-4576 | #### Indications for Use The AtriCure Cryo Module System is intended for use in the cryosurgical treatment of cardiac arrhythmias. The System consists of the AtriCure Cryo Module (ACM)-a non-sterile, reusable device-used with the Cryo1 cryo-ablation probe-a sterile, single use device-and/or the cryolCE cryo-ablation probe-a sterile, single use device. #### Predicate Devices The predicate devices for the AtriCure Cryo Module are the AtriCure frigitronics CCS-200 Cardiac Cryosurgical System (K811390) and the AtriCure Cryo1 cryo-ablation probe (K082074). #### Device Description The AtriCure Cryo Module (ACM) unit is a non-sterile reusable electro-mechanical and pneumatic cryogenic surgical system that delivers a cryogenic energy source, namely Nitrous Oxide, to a cryosurgical handpiece to create lines of ablation through cardiac tissue for the treatment of cardiac arrhythmias. #### Materials All materials used in the manufacture of the AtriCure Cryo Module are suitable for their intended use and suitable for use with pressurized nitrous oxide. The AtriCure Cryo Module is not intended for patient contact. {1}------------------------------------------------ K111042²/₂ ### Testing Appropriate product testing was conducted to evaluate conformance to product specification and substantial equivalence to predicate devices. Bench comparison testing, transit testing, electromagnetic compatibility, reliability, reliability testing, etc. were completed to show that the ACM is substantially equivalent and in conformance international standards and device specifications. #### Summary of Substantial Equivalence The AtriCure Cryo Module is equivalent to the predicate products. The intended use, method of operation, methods of construction and materials used, are substantially equivalent to existing legally marketed predicate products. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines that suggest wings and a stylized body. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 AtriCure, Inc. c/o Mr. Mark Job Third Party Official Regulatory Technology Services LLC. 1394 25th Street NW Buffalo, MN 55313 MAY 2 6 2011 Re: K111042 Trade/Device Name: AtriCure Cryo Module System (ACM, CRYO1 and cryoICE) Regulation Number: 21 CFR 878.4350 Regulation Name: Cryosurgical Unit and Accessories Regulatory Class: Class II (two) Product Code: GEH Dated: April 14, 2011 Received: April 15, 2011 Dear Mr. Job: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 -- Mr. Mark Job Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events} (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, D. Zadeh M.D. Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use 510(k) Number (if known) K111042 Device Name: AtriCure Cryo Module Indications for Use: The AtriCure Cryo Module System is intended for use in the cryosurgical treatment of cardiac arrhythmias. The System consists of the AtriCure Cryo Module (ACM)—a non-sterile, reusable device-used with the Cryo1 cryo-ablation probe-a sterile, single use device-and/or the cryolCE cryo-ablation probe-a sterile, single use device. × Prescription Use (Part 21 CRF 801 Subpart D) AND/OR Over-The-Counter Use (21 CRF 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) r (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number K111042
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%